Latest Regulatory Approvals News

iTech Minerals has significantly extended the strike length of gold-antimony mineralisation at its Reynolds Range Project, revealing new high-priority drill targets and advancing its lithium deal with SQM.

Osteopore Limited has posted a record AUD 835K revenue in Q2 CY25, driven by strong APAC sales and new European market access following EU MDR clearance. The company also advances clinical trials and refreshes key distribution channels.

CZR Resources has secured shareholder and regulatory approval to sell its Robe Mesa iron ore project for A$75 million, positioning the company to focus on promising gold and base metal exploration in Western Australia.

Astron Corporation has cleared major regulatory hurdles for its Donald Rare Earth and Mineral Sands Project, releasing a robust updated economic study that underscores the project's long-term value and advancing financing discussions.

Acrux Limited has secured a decade-long licensing agreement with Servacure to commercialise its FDA-approved Dapsone 5% Gel in Saudi Arabia, marking a strategic step in its global expansion.

Titanium Sands Limited has secured retention licenses for four critical exploration areas and is progressing its Environmental Impact Assessment in Sri Lanka, while engaging government officials and local landowners to navigate regulatory hurdles.

Silver Mines Limited progresses regulatory approvals for its flagship Bowdens Silver Project in NSW while acquiring promising US assets, enhancing its exploration pipeline with minimal upfront costs.

INOVIQ Limited reports breakthrough results for its ovarian cancer screening test achieving perfect early-stage detection, alongside promising advances in its CAR-exosome cancer therapy program.

Nyrada reports successful completion of five cohorts in its Phase I trial of Xolatryp with no safety concerns, alongside compelling preclinical neuro- and cardioprotective data. A Phase IIa trial targeting heart attack patients is slated for early 2026.

Next Science reports a 10% decline in quarterly product sales but advances a $50 million asset sale to Demetra Holdings, signaling a pivotal shift in its business strategy.

Jupiter Mines reports record FY2025 manganese sales and production at Tshipi mine, while Q4 earnings dip due to lower prices and higher costs. Exxaro’s planned majority acquisition signals a new chapter for the asset.

Southern Palladium has secured Environmental Authorisation for its Bengwenyama PGM project, completed an optimised Pre-Feasibility Study showing robust economics, and raised A$8 million to fund next-stage development.